KR100437873B1 - 프로스타글란딘 유도체의 제조방법 및 그의 입체특이적출발물질 - Google Patents
프로스타글란딘 유도체의 제조방법 및 그의 입체특이적출발물질 Download PDFInfo
- Publication number
- KR100437873B1 KR100437873B1 KR10-2001-0025011A KR20010025011A KR100437873B1 KR 100437873 B1 KR100437873 B1 KR 100437873B1 KR 20010025011 A KR20010025011 A KR 20010025011A KR 100437873 B1 KR100437873 B1 KR 100437873B1
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- compound
- reaction
- alcohol
- alkyl
- Prior art date
Links
- 239000007858 starting material Substances 0.000 title abstract description 8
- 238000004519 manufacturing process Methods 0.000 title description 7
- 150000003180 prostaglandins Chemical class 0.000 title description 4
- 230000000707 stereoselective effect Effects 0.000 title description 3
- 150000001875 compounds Chemical class 0.000 claims abstract description 57
- 238000000034 method Methods 0.000 claims abstract description 36
- 150000002576 ketones Chemical class 0.000 claims abstract description 11
- 150000001350 alkyl halides Chemical class 0.000 claims abstract description 8
- 125000006241 alcohol protecting group Chemical group 0.000 claims abstract description 4
- 238000006243 chemical reaction Methods 0.000 claims description 47
- 125000006239 protecting group Chemical group 0.000 claims description 9
- 229910052987 metal hydride Inorganic materials 0.000 claims description 7
- 150000004681 metal hydrides Chemical class 0.000 claims description 7
- UBJFKNSINUCEAL-UHFFFAOYSA-N lithium;2-methylpropane Chemical compound [Li+].C[C-](C)C UBJFKNSINUCEAL-UHFFFAOYSA-N 0.000 claims description 6
- 238000010511 deprotection reaction Methods 0.000 claims description 5
- 229910052760 oxygen Inorganic materials 0.000 claims description 5
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 claims description 4
- DOBRDRYODQBAMW-UHFFFAOYSA-N copper(i) cyanide Chemical compound [Cu+].N#[C-] DOBRDRYODQBAMW-UHFFFAOYSA-N 0.000 claims description 4
- 229910052736 halogen Inorganic materials 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 239000007818 Grignard reagent Substances 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- BGTOWKSIORTVQH-HOSYLAQJSA-N cyclopentanone Chemical group O=[13C]1CCCC1 BGTOWKSIORTVQH-HOSYLAQJSA-N 0.000 claims description 3
- 150000004795 grignard reagents Chemical class 0.000 claims description 3
- 125000005843 halogen group Chemical group 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 239000011777 magnesium Substances 0.000 claims description 3
- RGSFGYAAUTVSQA-UHFFFAOYSA-N pentamethylene Natural products C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 claims description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 2
- XCIXKGXIYUWCLL-HOSYLAQJSA-N cyclopentanol Chemical group O[13CH]1CCCC1 XCIXKGXIYUWCLL-HOSYLAQJSA-N 0.000 claims description 2
- 229910052749 magnesium Inorganic materials 0.000 claims description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 claims description 2
- 239000012279 sodium borohydride Substances 0.000 claims description 2
- 238000007259 addition reaction Methods 0.000 abstract description 3
- 125000000468 ketone group Chemical group 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 38
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 33
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 33
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 31
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 30
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 30
- -1 13,14-dihydro-PGF 2α ester Chemical class 0.000 description 20
- 238000002360 preparation method Methods 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 239000012044 organic layer Substances 0.000 description 13
- 239000002904 solvent Substances 0.000 description 13
- 229920006395 saturated elastomer Polymers 0.000 description 11
- ILMRJRBKQSSXGY-UHFFFAOYSA-N tert-butyl(dimethyl)silicon Chemical group C[Si](C)C(C)(C)C ILMRJRBKQSSXGY-UHFFFAOYSA-N 0.000 description 11
- 238000010898 silica gel chromatography Methods 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 9
- 239000007864 aqueous solution Substances 0.000 description 9
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 8
- HZNVUJQVZSTENZ-UHFFFAOYSA-N 2,3-dichloro-5,6-dicyano-1,4-benzoquinone Chemical group ClC1=C(Cl)C(=O)C(C#N)=C(C#N)C1=O HZNVUJQVZSTENZ-UHFFFAOYSA-N 0.000 description 6
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 6
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 6
- 229910021589 Copper(I) bromide Inorganic materials 0.000 description 5
- DVSWUMQTYMRVDZ-INIZCTEOSA-N [(3s)-1-bromo-5-phenylpentan-3-yl]oxy-tert-butyl-dimethylsilane Chemical compound CC(C)(C)[Si](C)(C)O[C@H](CCBr)CCC1=CC=CC=C1 DVSWUMQTYMRVDZ-INIZCTEOSA-N 0.000 description 5
- 239000012267 brine Substances 0.000 description 5
- 239000010410 layer Substances 0.000 description 5
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 230000032050 esterification Effects 0.000 description 4
- 238000005886 esterification reaction Methods 0.000 description 4
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 4
- 235000019341 magnesium sulphate Nutrition 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 125000003545 alkoxy group Chemical group 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 150000002596 lactones Chemical class 0.000 description 3
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 3
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 3
- BZKFMUIJRXWWQK-UHFFFAOYSA-N Cyclopentenone Chemical compound O=C1CCC=C1 BZKFMUIJRXWWQK-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 2
- FPABVZYYTCHNMK-YNRDDPJXSA-N PGF2alpha isopropyl ester Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(=O)OC(C)C FPABVZYYTCHNMK-YNRDDPJXSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 238000007239 Wittig reaction Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical group 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 150000002118 epoxides Chemical class 0.000 description 2
- 125000005842 heteroatom Chemical group 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 239000001301 oxygen Chemical group 0.000 description 2
- 150000003138 primary alcohols Chemical class 0.000 description 2
- GRJJQCWNZGRKAU-UHFFFAOYSA-N pyridin-1-ium;fluoride Chemical compound F.C1=CC=NC=C1 GRJJQCWNZGRKAU-UHFFFAOYSA-N 0.000 description 2
- 125000004434 sulfur atom Chemical group 0.000 description 2
- 238000001308 synthesis method Methods 0.000 description 2
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- FWOSUYGUMQKGTN-INIZCTEOSA-N (3s)-3-[tert-butyl(dimethyl)silyl]oxy-5-phenylpentan-1-ol Chemical compound CC(C)(C)[Si](C)(C)O[C@H](CCO)CCC1=CC=CC=C1 FWOSUYGUMQKGTN-INIZCTEOSA-N 0.000 description 1
- PAAZPARNPHGIKF-UHFFFAOYSA-N 1,2-dibromoethane Chemical compound BrCCBr PAAZPARNPHGIKF-UHFFFAOYSA-N 0.000 description 1
- CTEWNSAFZZKQLZ-UHFFFAOYSA-N 1-[(4-methoxyphenyl)methoxy]-5-phenylpentan-3-ol Chemical compound C1=CC(OC)=CC=C1COCCC(O)CCC1=CC=CC=C1 CTEWNSAFZZKQLZ-UHFFFAOYSA-N 0.000 description 1
- ZOTQIPMMMCLNGW-UHFFFAOYSA-N 2-[2-[(4-methoxyphenyl)methoxy]ethyl]oxirane Chemical compound C1=CC(OC)=CC=C1COCCC1OC1 ZOTQIPMMMCLNGW-UHFFFAOYSA-N 0.000 description 1
- 241000349731 Afzelia bipindensis Species 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 230000031709 bromination Effects 0.000 description 1
- 238000005893 bromination reaction Methods 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- YDVNLQGCLLPHAH-UHFFFAOYSA-N dichloromethane;hydrate Chemical compound O.ClCCl YDVNLQGCLLPHAH-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- SNHOZPMHMQQMNI-UHFFFAOYSA-N lithium;2h-thiophen-2-ide Chemical compound [Li+].C=1C=[C-]SC=1 SNHOZPMHMQQMNI-UHFFFAOYSA-N 0.000 description 1
- IHLVCKWPAMTVTG-UHFFFAOYSA-N lithium;carbanide Chemical compound [Li+].[CH3-] IHLVCKWPAMTVTG-UHFFFAOYSA-N 0.000 description 1
- SCEZYJKGDJPHQO-UHFFFAOYSA-M magnesium;methanidylbenzene;chloride Chemical compound [Mg+2].[Cl-].[CH2-]C1=CC=CC=C1 SCEZYJKGDJPHQO-UHFFFAOYSA-M 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
- 239000012038 nucleophile Substances 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- SECORWWIPDMVOT-SFHVURJKSA-N propan-2-yl 7-[(3r)-3-[tert-butyl(dimethyl)silyl]oxy-5-oxocyclopenten-1-yl]hept-5-enoate Chemical compound CC(C)OC(=O)CCCC=CCC1=C[C@H](O[Si](C)(C)C(C)(C)C)CC1=O SECORWWIPDMVOT-SFHVURJKSA-N 0.000 description 1
- 238000007142 ring opening reaction Methods 0.000 description 1
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- XTLKDLJWNGDWKV-DEOSSOPVSA-N tert-butyl-[(3s)-1-[(4-methoxyphenyl)methoxy]-5-phenylpentan-3-yl]oxy-dimethylsilane Chemical compound C1=CC(OC)=CC=C1COCC[C@@H](O[Si](C)(C)C(C)(C)C)CCC1=CC=CC=C1 XTLKDLJWNGDWKV-DEOSSOPVSA-N 0.000 description 1
- BCNZYOJHNLTNEZ-UHFFFAOYSA-N tert-butyldimethylsilyl chloride Chemical compound CC(C)(C)[Si](C)(C)Cl BCNZYOJHNLTNEZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (5)
- 제 1 단계로, 하기 화학식 3의 15S-알콜을 포함하는 알킬할라이드를 그의 큐푸레이트로 전환시킨 후, 하기 화학식 2의 α,β-불포화케톤에 입체선택적으로 1,4-첨가반응시켜 하기 화학식 4의 화합물을 생성시키고;제 2 단계로, 생성된 화학식 4의 화합물에서 시클로펜타논환의 케톤을 입체장애가 큰 메탈 하이드라이드를 이용하여 환원시켜 하기 화학식 5의 α-알콜 화합물을 얻은 다음;제 3 단계로, 화학식 5의 화합물에서 시클로펜탄올환과 ω-체인의 알콜 보호기를 탈보호화함을 특징으로 하는, 하기 화학식 1 의 화합물을 제조하는 방법:[화학식 3][화학식 2][화학식 4][화학식 5][화학식 1]상기식에서,R'은 C2-C4-알킬; 할로겐, C1-C5-알킬, C1-C4-알콕시, CF3, C1-C3-알리페틱 아실아미노에 의해 치환되거나 비치환된 페닐; C3-C7-시클로알킬; 또는 C3-C7-시클로알케닐을 나타내고,X는 CH2, O, 또는 S을 나타내며,Y는 이탈기를 나타내고,R" 및 R2는 하이드록시보호기를 나타내고,R1은 H 또는 C1-C5-알킬을 나타낸다.
- 제 1 항에 있어서, 화학식 3 의 화합물에i) t-BuLi을 가한 다음, CuCN, (2-티에닐)Cu(CN)Li 및 MeCu(CN)Li에서 선택된 1종의 화합물을 가하거나;ii) 마그네슘을 가하여 형성시킨 그리그나드 시약에 CuBr·DMS를 가하여그의 큐푸레이트로 전환시키는 방법.
- 제 1항에 있어서, 메탈하이드라이드가 소디움보로하이드리드(NaBH4), L-셀렉트라이드(L-selectride), N-셀렉트라이드(N-selectride), 및 K-셀렉트라이드(K-selectride)중에서 선택된 1종인 방법.
- 제 1항에 있어서, H+또는 F-가 존재하는 조건하에서 알콜보호기의 탈보호화 과정을 수행하는 방법.
- 하기 화학식 3a의 화합물[화학식 3a]상기식에서,Y'은 Br 또는 I이고,R"는 하이드록시보호기를 나타낸다.
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2001-0025011A KR100437873B1 (ko) | 2001-05-08 | 2001-05-08 | 프로스타글란딘 유도체의 제조방법 및 그의 입체특이적출발물질 |
HU0303985A HU230726B1 (hu) | 2001-05-08 | 2002-05-07 | Eljárás prosztaglandin-származékok és sztereospecifikus kiindulási vegyületeik előállítására |
PCT/KR2002/000845 WO2002090324A1 (en) | 2001-05-08 | 2002-05-07 | Process for preparing prostaglandin derivatives and stereospecific starting material thereof |
CZ20033033A CZ20033033A3 (en) | 2001-05-08 | 2002-05-07 | Process for preparing prostaglandin derivatives and stereospecific starting material thereof |
US10/476,115 US6852880B2 (en) | 2001-05-08 | 2002-05-07 | Process for preparing prostalglandin derivatives and stereospecific starting material thereof |
EP02769230.0A EP1385819B1 (en) | 2001-05-08 | 2002-05-07 | Process for preparing prostaglandin derivatives and stereospecific starting material thereof |
JP2002587404A JP3989377B2 (ja) | 2001-05-08 | 2002-05-07 | プロスタグランジン誘導体の製造方法及びその立体特異的出発物質 |
IL15863402A IL158634A0 (en) | 2001-05-08 | 2002-05-07 | Process for preparing prostaglandin derivatives and stereospecific starting material thereof |
IL158634A IL158634A (en) | 2001-05-08 | 2003-10-28 | Process for preparing prostaglandin derivatives and stereospecific starting material therefor |
US11/021,284 US6989458B2 (en) | 2001-05-08 | 2004-12-22 | Process for preparing prostaglandin derivatives and stereospecific starting material thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2001-0025011A KR100437873B1 (ko) | 2001-05-08 | 2001-05-08 | 프로스타글란딘 유도체의 제조방법 및 그의 입체특이적출발물질 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20020085490A KR20020085490A (ko) | 2002-11-16 |
KR100437873B1 true KR100437873B1 (ko) | 2004-06-26 |
Family
ID=19709195
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2001-0025011A KR100437873B1 (ko) | 2001-05-08 | 2001-05-08 | 프로스타글란딘 유도체의 제조방법 및 그의 입체특이적출발물질 |
Country Status (8)
Country | Link |
---|---|
US (2) | US6852880B2 (ko) |
EP (1) | EP1385819B1 (ko) |
JP (1) | JP3989377B2 (ko) |
KR (1) | KR100437873B1 (ko) |
CZ (1) | CZ20033033A3 (ko) |
HU (1) | HU230726B1 (ko) |
IL (2) | IL158634A0 (ko) |
WO (1) | WO2002090324A1 (ko) |
Families Citing this family (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100437873B1 (ko) * | 2001-05-08 | 2004-06-26 | 연성정밀화학(주) | 프로스타글란딘 유도체의 제조방법 및 그의 입체특이적출발물질 |
KR100903311B1 (ko) * | 2002-09-18 | 2009-06-17 | 연성정밀화학(주) | 프로스타글란딘 유도체의 제조방법 및 그를 위한 출발물질 |
US7109371B2 (en) | 2004-01-05 | 2006-09-19 | Johnson Matthey Public Limited Company | Prostaglandin synthesis |
KR100782835B1 (ko) * | 2005-01-29 | 2007-12-06 | 삼성전자주식회사 | 캡션 정보의 출력시점 및 출력 우선순위를 조절하는 방법및 그 장치 |
PL212658B1 (pl) | 2005-04-18 | 2012-11-30 | Inst Farmaceutyczny | Sposób otrzymywania pochodnych 13,14-dihydro-PGF<sub>2</sub><sub>α</sub> |
EP2390154A1 (en) * | 2005-10-31 | 2011-11-30 | Toyota Jidosha Kabushiki Kaisha | Parking support device |
US8761568B2 (en) * | 2005-12-20 | 2014-06-24 | Vestel Elektronik Sanayi Ve Ticaret A.S. | Method and apparatus for synchronizing subtitles with a video |
US8546114B2 (en) | 2006-01-18 | 2013-10-01 | Chirogate International Inc. | Processes for the preparation of optically active cyclopentenones and cyclopentenones prepared therefrom |
EP1810967B1 (en) | 2006-01-18 | 2014-07-30 | Chirogate International Inc. | Processes and intermediates for the preparations of prostaglandins |
US7511168B2 (en) * | 2006-01-18 | 2009-03-31 | Shih-Yi Wei | Processes and intermediates for the preparations of prostaglandins |
AR071312A1 (es) * | 2008-04-09 | 2010-06-09 | Scinopharm Taiwan Ltd | Proceso para la preparacion de analogos de prostaglandina y sus intermediarios |
US9674458B2 (en) | 2009-06-03 | 2017-06-06 | Flir Systems, Inc. | Smart surveillance camera systems and methods |
US9473681B2 (en) | 2011-06-10 | 2016-10-18 | Flir Systems, Inc. | Infrared camera system housing with metalized surface |
US9517679B2 (en) | 2009-03-02 | 2016-12-13 | Flir Systems, Inc. | Systems and methods for monitoring vehicle occupants |
US9635285B2 (en) | 2009-03-02 | 2017-04-25 | Flir Systems, Inc. | Infrared imaging enhancement with fusion |
US9998697B2 (en) | 2009-03-02 | 2018-06-12 | Flir Systems, Inc. | Systems and methods for monitoring vehicle occupants |
US9208542B2 (en) | 2009-03-02 | 2015-12-08 | Flir Systems, Inc. | Pixel-wise noise reduction in thermal images |
US9843742B2 (en) | 2009-03-02 | 2017-12-12 | Flir Systems, Inc. | Thermal image frame capture using de-aligned sensor array |
US10244190B2 (en) | 2009-03-02 | 2019-03-26 | Flir Systems, Inc. | Compact multi-spectrum imaging with fusion |
US9235876B2 (en) | 2009-03-02 | 2016-01-12 | Flir Systems, Inc. | Row and column noise reduction in thermal images |
US9756264B2 (en) | 2009-03-02 | 2017-09-05 | Flir Systems, Inc. | Anomalous pixel detection |
US9986175B2 (en) | 2009-03-02 | 2018-05-29 | Flir Systems, Inc. | Device attachment with infrared imaging sensor |
US9451183B2 (en) | 2009-03-02 | 2016-09-20 | Flir Systems, Inc. | Time spaced infrared image enhancement |
US9948872B2 (en) | 2009-03-02 | 2018-04-17 | Flir Systems, Inc. | Monitor and control systems and methods for occupant safety and energy efficiency of structures |
US10757308B2 (en) | 2009-03-02 | 2020-08-25 | Flir Systems, Inc. | Techniques for device attachment with dual band imaging sensor |
USD765081S1 (en) | 2012-05-25 | 2016-08-30 | Flir Systems, Inc. | Mobile communications device attachment with camera |
KR101045935B1 (ko) | 2009-03-11 | 2011-07-01 | 연성정밀화학(주) | 프로스타글란딘 유도체의 제조방법 |
US9819880B2 (en) | 2009-06-03 | 2017-11-14 | Flir Systems, Inc. | Systems and methods of suppressing sky regions in images |
US9756262B2 (en) | 2009-06-03 | 2017-09-05 | Flir Systems, Inc. | Systems and methods for monitoring power systems |
US9292909B2 (en) | 2009-06-03 | 2016-03-22 | Flir Systems, Inc. | Selective image correction for infrared imaging devices |
US10091439B2 (en) | 2009-06-03 | 2018-10-02 | Flir Systems, Inc. | Imager with array of multiple infrared imaging modules |
US9843743B2 (en) | 2009-06-03 | 2017-12-12 | Flir Systems, Inc. | Infant monitoring systems and methods using thermal imaging |
US9716843B2 (en) | 2009-06-03 | 2017-07-25 | Flir Systems, Inc. | Measurement device for electrical installations and related methods |
CA2768154C (en) | 2009-07-13 | 2018-02-13 | Irix Pharmaceuticals | Synthesis of prostanoids |
CN102481301A (zh) | 2009-09-17 | 2012-05-30 | 千寿制药株式会社 | 含有拉坦前列素的水性滴眼剂以及抑制拉坦前列素对树脂的吸附的方法 |
US9848134B2 (en) | 2010-04-23 | 2017-12-19 | Flir Systems, Inc. | Infrared imager with integrated metal layers |
US9207708B2 (en) | 2010-04-23 | 2015-12-08 | Flir Systems, Inc. | Abnormal clock rate detection in imaging sensor arrays |
US9706138B2 (en) | 2010-04-23 | 2017-07-11 | Flir Systems, Inc. | Hybrid infrared sensor array having heterogeneous infrared sensors |
US9918023B2 (en) | 2010-04-23 | 2018-03-13 | Flir Systems, Inc. | Segmented focal plane array architecture |
US9900526B2 (en) | 2011-06-10 | 2018-02-20 | Flir Systems, Inc. | Techniques to compensate for calibration drifts in infrared imaging devices |
US10051210B2 (en) | 2011-06-10 | 2018-08-14 | Flir Systems, Inc. | Infrared detector array with selectable pixel binning systems and methods |
US9235023B2 (en) | 2011-06-10 | 2016-01-12 | Flir Systems, Inc. | Variable lens sleeve spacer |
US9509924B2 (en) | 2011-06-10 | 2016-11-29 | Flir Systems, Inc. | Wearable apparatus with integrated infrared imaging module |
CN103828343B (zh) | 2011-06-10 | 2017-07-11 | 菲力尔系统公司 | 基于行的图像处理和柔性存储系统 |
US9058653B1 (en) | 2011-06-10 | 2015-06-16 | Flir Systems, Inc. | Alignment of visible light sources based on thermal images |
EP2719165B1 (en) | 2011-06-10 | 2018-05-02 | Flir Systems, Inc. | Non-uniformity correction techniques for infrared imaging devices |
US9961277B2 (en) | 2011-06-10 | 2018-05-01 | Flir Systems, Inc. | Infrared focal plane array heat spreaders |
US10079982B2 (en) | 2011-06-10 | 2018-09-18 | Flir Systems, Inc. | Determination of an absolute radiometric value using blocked infrared sensors |
US9143703B2 (en) | 2011-06-10 | 2015-09-22 | Flir Systems, Inc. | Infrared camera calibration techniques |
US10169666B2 (en) | 2011-06-10 | 2019-01-01 | Flir Systems, Inc. | Image-assisted remote control vehicle systems and methods |
CN103748867B (zh) | 2011-06-10 | 2019-01-18 | 菲力尔系统公司 | 低功耗和小形状因子红外成像 |
US10841508B2 (en) | 2011-06-10 | 2020-11-17 | Flir Systems, Inc. | Electrical cabinet infrared monitor systems and methods |
US10389953B2 (en) | 2011-06-10 | 2019-08-20 | Flir Systems, Inc. | Infrared imaging device having a shutter |
US9706137B2 (en) | 2011-06-10 | 2017-07-11 | Flir Systems, Inc. | Electrical cabinet infrared monitor |
US9811884B2 (en) | 2012-07-16 | 2017-11-07 | Flir Systems, Inc. | Methods and systems for suppressing atmospheric turbulence in images |
WO2014014957A1 (en) | 2012-07-16 | 2014-01-23 | Flir Systems, Inc. | Methods and systems for suppressing noise in images |
US9115109B2 (en) | 2013-08-15 | 2015-08-25 | Chirogate International Inc. | Processes and intermediates for the preparations of isomer free prostaglandins |
KR102311896B1 (ko) | 2013-09-30 | 2021-10-14 | 패턴 에이피아이 서비시즈 인코포레이티드 | 복분해를 사용하는 프로스타글란딘 및 프로스타글란딘 중간체의 합성 경로 |
US9973692B2 (en) | 2013-10-03 | 2018-05-15 | Flir Systems, Inc. | Situational awareness by compressed display of panoramic views |
US11297264B2 (en) | 2014-01-05 | 2022-04-05 | Teledyne Fur, Llc | Device attachment with dual band imaging sensor |
KR20160015100A (ko) | 2014-07-30 | 2016-02-12 | 미래파인켐 주식회사 | 프로스타글란딘 중간체의 제조방법 |
KR20170025682A (ko) | 2015-08-31 | 2017-03-08 | 미래파인켐 주식회사 | 프로스타글란딘 유도체의 신규한 제조방법 |
KR101830693B1 (ko) | 2016-04-28 | 2018-02-21 | 연성정밀화학(주) | 트레프로스티닐의 제조방법 및 이를 위한 중간체 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1507211A (en) * | 1975-02-14 | 1978-04-12 | Ono Pharmaceutical Co | Prostaglandin analogues |
JPS5829710A (ja) * | 1981-03-25 | 1983-02-22 | ジ・アツプジヨン・カンパニ− | Pg類による骨孔症の治療 |
DE3743824C2 (de) * | 1987-12-23 | 1997-03-06 | Hoechst Ag | Verfahren zur enzymatischen Racematspaltung von racemischen Alkoholen mit/in Vinylestern durch Umesterung |
EP0569046B1 (en) | 1988-09-06 | 2002-11-13 | Pharmacia Aktiebolag | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
US5352708A (en) * | 1992-09-21 | 1994-10-04 | Allergan, Inc. | Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
SE9303444D0 (sv) | 1993-10-20 | 1993-10-20 | Kabi Pharmacia Ab | New use of prostaglandins |
US6124344A (en) * | 1993-12-28 | 2000-09-26 | Allergan Sales, Inc. | Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
WO1999012897A1 (en) * | 1997-09-09 | 1999-03-18 | The Procter & Gamble Company | A process for making epoxide intermediates |
US5977173A (en) * | 1997-09-09 | 1999-11-02 | Wos; John August | Aromatic C16 -C20 -substituted tetrahydro prostaglandins useful as FP agonists |
US6048895A (en) * | 1997-09-09 | 2000-04-11 | The Procter & Gamble Company | Aromatic C16-C20 substituted tetrahydro prostaglandins useful as FP agonists |
WO1999044990A1 (en) * | 1998-03-06 | 1999-09-10 | Astrazeneca Ab | Novel process |
TR200002795T2 (tr) * | 1998-03-31 | 2001-01-22 | The Procter & Gamble Company | FP Agonistleri olarak yararlı olan C11 oksimil ve hidroksilamino prostaglandinleri. |
US6388128B1 (en) * | 1998-10-05 | 2002-05-14 | Alcon Manufacturing, Ltd. | Stannane synthesis of prostanoids |
ATE283256T1 (de) * | 1999-03-05 | 2004-12-15 | Univ Duke | C-16 ungesätigte fp-selektive prostaglandin analoge |
KR100437873B1 (ko) * | 2001-05-08 | 2004-06-26 | 연성정밀화학(주) | 프로스타글란딘 유도체의 제조방법 및 그의 입체특이적출발물질 |
BR0211204A (pt) * | 2001-07-17 | 2004-07-13 | Upjohn Co | Processo e intermediários para preparar latanoprost |
-
2001
- 2001-05-08 KR KR10-2001-0025011A patent/KR100437873B1/ko active IP Right Grant
-
2002
- 2002-05-07 US US10/476,115 patent/US6852880B2/en not_active Expired - Lifetime
- 2002-05-07 IL IL15863402A patent/IL158634A0/xx unknown
- 2002-05-07 JP JP2002587404A patent/JP3989377B2/ja not_active Expired - Lifetime
- 2002-05-07 CZ CZ20033033A patent/CZ20033033A3/cs unknown
- 2002-05-07 EP EP02769230.0A patent/EP1385819B1/en not_active Expired - Lifetime
- 2002-05-07 HU HU0303985A patent/HU230726B1/hu not_active IP Right Cessation
- 2002-05-07 WO PCT/KR2002/000845 patent/WO2002090324A1/en active Application Filing
-
2003
- 2003-10-28 IL IL158634A patent/IL158634A/en active IP Right Grant
-
2004
- 2004-12-22 US US11/021,284 patent/US6989458B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
KR20020085490A (ko) | 2002-11-16 |
US20050192451A1 (en) | 2005-09-01 |
US6989458B2 (en) | 2006-01-24 |
JP2004526802A (ja) | 2004-09-02 |
US20040116693A1 (en) | 2004-06-17 |
US6852880B2 (en) | 2005-02-08 |
EP1385819B1 (en) | 2015-12-23 |
JP3989377B2 (ja) | 2007-10-10 |
EP1385819A1 (en) | 2004-02-04 |
HU230726B1 (hu) | 2017-12-28 |
HUP0303985A2 (hu) | 2004-04-28 |
CZ20033033A3 (en) | 2004-03-17 |
EP1385819A4 (en) | 2005-01-26 |
WO2002090324A1 (en) | 2002-11-14 |
HUP0303985A3 (en) | 2012-12-28 |
IL158634A0 (en) | 2004-05-12 |
IL158634A (en) | 2009-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100437873B1 (ko) | 프로스타글란딘 유도체의 제조방법 및 그의 입체특이적출발물질 | |
JP4475943B2 (ja) | プロスタグランジン及びそれらの類縁体の製法 | |
JP5485980B2 (ja) | プロスタグランジン類似物の製造方法及びその中間体 | |
JP2012519163A (ja) | プロスタグランジン誘導体の製造方法 | |
JP2010100629A (ja) | プロスタグランジン誘導体の製造方法及びその出発物質 | |
PL212658B1 (pl) | Sposób otrzymywania pochodnych 13,14-dihydro-PGF<sub>2</sub><sub>α</sub> | |
JP2020045334A (ja) | ルビプロストンの調製方法およびその中間体 | |
KR940003361B1 (ko) | 이소카르바시클린류 및 그의 제조방법 | |
JPS60169459A (ja) | フエノキシプロスタトリエン酸誘導体の製造法 | |
US6437152B1 (en) | Intermediate for the synthesis of prostaglandins | |
JPH02145532A (ja) | シクロペンテンヘプテン酸誘導体およびその製造方法 | |
KR20070076548A (ko) | 프로스타글란딘 제조를 위한 방법 및 중간체 | |
JP4153998B2 (ja) | プロスタグランジン類の製造方法 | |
HU190996B (en) | Process for preparing prostaglandin e down 1 compounds | |
JP2670545B2 (ja) | 新規な方法及び中間体類 | |
PL94475B1 (pl) | Sposob wytwarzania pochodnych prostaglandyny | |
JP2737214B2 (ja) | 4―ヒドロキシ―2―シクロペンテノン誘導体の製造法 | |
JPS6187638A (ja) | 2,3−二置換−4−置換シクロペンタノン類の製造法 | |
JPS60181068A (ja) | 6−置換プロスタグランジンe↓1類およびその製造法 | |
TW202248197A (zh) | 製備苯并前列環素類似物之方法及中間物,及由其製得之苯并前列環素類似物 | |
JP2023165632A (ja) | カルバプロスタサイクリン類縁体の製造のための方法及び中間体 | |
CA2362132C (en) | Novel intermediate for the synthesis of prostaglandins | |
JPS62195358A (ja) | (5e)−プロスタグランジンe↓2類の製造法 | |
CN114249706A (zh) | 一种用于合成环前列腺素衍生物的中间体的制备方法 | |
JPS647063B2 (ko) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130604 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20140611 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20150604 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20160324 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20170316 Year of fee payment: 14 |
|
FPAY | Annual fee payment |
Payment date: 20180316 Year of fee payment: 15 |